Member Login
  1. Stocks
    2. /
  2. Bausch Health Companies Inc. (NYSE: BHC)
    3. /

NYSE:BHC (Bausch Health Companies Inc.)

About BHC

A global specialty pharmaceutical company that develops, manufactures and markets a range of pharmaceutical products, primarily in the areas of neurology, infectious disease, and dermatology.
Financial Market Data copyright © 2024 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.

    • Bausch Health Companies Inc. (NYSE: BHC) Latest News

    The Motley Fool
    Investing

    Could Valeant Pharmaceuticals Intl Inc. Be the Rebound Stock of the Year?

    | Joey Frenette

    Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) is a hot business with promising revenue drivers in the new year. With the tailwinds…

    Read more »

    Investing

    Is Buying Oversold Stocks an Effective Strategy?

    | David Jagielski

    If you had bought Canadian National Railway Company (TSX:CNR)(NYSE:CNI) back when it was oversold in August, you would have earned a…

    Read more »

    Investing

    Will Investors Finally See the Demise of This Company in 2018?

    | Ryan Goldsman

    With an increasing interest expense, shares of Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) may be ready for bankruptcy in 2018.

    Read more »

    Investing

    3 Reasons the Canadian Economy Could Decline in 2018

    | David Jagielski

    Dollarama Inc. (TSX:DOL) and other retailers are going to be severely impacted by rising minimum wages in 2018.

    Read more »

    Tech Stocks

    3 Turnaround Candidates for 2018 You Should Consider Now

    | Demetris Afxentiou

    Beleaguered companies such as Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) and others could stand to finally see a turnaround in 2018.

    Read more »

    The Motley Fool
    Investing

    Valeant Pharmaceuticals Intl Inc Jumped 35% Last Month: Is the Stock Taking off?

    | David Jagielski

    Valeant Pharmaceuticals Intl Inc (TSX:VRX)(NYSE:VRX) has seen its stock soar recently and investors may want to take a second look…

    Read more »

    The Motley Fool
    Investing

    Why Valeant Pharmaceuticals Intl Inc. Surged Almost 10% Today

    | Karen Thomas, MSc, CFA

    Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) is clearly making progress under its new CEO, but there are still many hurdles to…

    Read more »

    time is money compounding
    Investing

    Valeant Pharmaceuticals Intl Inc. Is up! Time to Buy?

    | Demetris Afxentiou

    Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) continues to pay down and refinance its debt to more favourable terms. As the business…

    Read more »

    Investing

    After Reaching Another 52-Week High, Valeant Pharmaceuticals Intl Inc. Should Still Be Avoided at All Costs!

    | Ryan Goldsman

    Shares of Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) should still be avoided at all costs.

    Read more »

    Investing

    2 Fallen Stars That Will Fly High Again

    | Joey Frenette

    BlackBerry Ltd. (TSX:BB)(NYSE:BB) and Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) are two businesses that have reinvented themselves. Here's why you should…

    Read more »

    Investing

    4 Non-Cannabis Stocks That Have Grown 25% in the Past 3 Months

    | David Jagielski

    Bombardier, Inc. (TSX:BBD.B) and these three other stocks could provide investors with excellent growth opportunities.

    Read more »

    The Motley Fool
    Investing

    Queue the 2018 Rebound for Valeant Pharmaceuticals Intl Inc.

    | Joey Frenette

    Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) may be slated to enjoy a huge 2018. Here's why investors may want to back…

    Read more »